Additional file 1 of To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial

M.J.H. Begemann (Creator)
Ilse A. Thompson (Creator)
W. Veling (Creator)
Shiral S. Gangadin (Contributor)
Chris N.W. Geraets (Creator)
Erna Van 'T Hag (Contributor)
Sanne J. Müller-Kuperus (Creator)
P.P. Oomen (Creator)
Alban E. Voppel (Creator)
M van der Gaag (Contributor)
Martijn J. Kikkert (Department of Research, Arkin Mental Health Care) (Creator)
J. Van Os (Contributor)
H. Filip E. Smit (Contributor)
Rikus H. Knegtering (Creator)
Sybren Wiersma (Creator)
Luyken H. Stouten (Contributor)
Harm J. Gijsman (Creator)
Lex Wunderink (Creator)
Anton B.P. Staring (Creator)
Selene R.T. Veerman (Creator)
Amrita G.S. Mahabir (Creator)
Jörg Kurkamp (Creator)
G.H.M. Pijnenborg (Creator)
Natalie D. Veen (Creator)
M. Marcelis (Creator)
Koen P. Grootens (Creator)
Gunnar Faber (Creator)
N.J.M. Van Beveren (Contributor)
Agaath Been (Creator)
Truus Van Den Brink (Contributor)
Maarten Bak (Creator)
T. van Amelsvoort (Contributor)
A.M. Ruissen (Creator)
Christine Blanke (Creator)
Karin Groen (Creator)
L. de Haan (Contributor)
Iris E.C. Sommer (Creator)

Dataset / Software

Description

Additional file 1: Table S1. Tapering off schedules.

Date made available	2020
Publisher	Figshare

DOI
10.6084/m9.figshare.11826258

Access Dataset

CC BY + CC0

1 Article

To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial
Begemann, M. J. H., Thompson, I. A., Veling, W., Gangadin, S. S., Geraets, C. N. W., Van 'T Hag, E., Müller-Kuperus, S. J., Oomen, P. P., Voppel, A. E., Van Der Gaag, M., Kikkert, M. J., Van Os, J., Smit, H. F. E., Knegtering, R. H., Wiersma, S., Stouten, L. H., Gijsman, H. J., Wunderink, L., Staring, A. B. P. & Veerman, S. R. T. & 17 others, Mahabir, A. G. S., Kurkamp, J., Pijnenborg, G. H. M., Veen, N. D., Marcelis, M., Grootens, K. P., Faber, G., Van Beveren, N. J., Been, A., Van Den Brink, T., Bak, M., Van Amelsvoort, T. A. M. J., Ruissen, A., Blanke, C., Groen, K., De Haan, L. & Sommer, I. E. C., 7 Feb 2020, In: Trials. 21, p. 1-19 19 p., 147.
Research output: Contribution to Journal › Article › Academic › peer-review

Open Access

Cite this

Begemann, M. J. H. (Creator), Thompson, I. A. (Creator), Veling, W. (Creator), Gangadin, S. S. (Contributor), Geraets, C. N. W. (Creator), Van 'T Hag, E. (Contributor), Müller-Kuperus, S. J. (Creator), Oomen, P. P. (Creator), Voppel, A. E. (Creator), Van Der Gaag, M. (Contributor), Kikkert, M. J. (Creator), Van Os, J. (Contributor), Smit, H. F. E. (Contributor), Knegtering, R. H. (Creator), Wiersma, S. (Creator), Stouten, L. H. (Contributor), Gijsman, H. J. (Creator), Wunderink, L. (Creator), Staring, A. B. P. (Creator), Veerman, S. R. T. (Creator), Mahabir, A. G. S. (Creator), Kurkamp, J. (Creator), Pijnenborg, G. H. M. (Creator), Veen, N. D. (Creator), Marcelis, M. (Creator), Grootens, K. P. (Creator), Faber, G. (Creator), Van Beveren, N. J. (Contributor), Been, A. (Creator), Van Den Brink, T. (Contributor), Bak, M. (Creator), Van Amelsvoort, T. A. M. J. (Contributor), Ruissen, A. (Creator), Blanke, C. (Creator), Groen, K. (Creator), De Haan, L. (Contributor), Sommer, I. E. C. (Creator) (2020). Additional file 1 of To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial. Figshare. 10.6084/m9.figshare.11826258

Additional file 1 of To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial

Description

DOI

Access Dataset

Research output

To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial

Cite this